Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Wales’ New Treatments Fund

ABPI London offices

ABPI to tighten up transparency compliance

Hires independent third party to monitor for incidents of non-compliance

- PMLiVE

NICE recommends BMS-Pfizer’s Eliquis to prevent stroke

Joins Xarelto and Pradaxa anticoagulants as potential warfarin replacement

- PMLiVE

New directors at NHS Confederation

Johnny Marshall named director of policy and Matt Tee named chief operating officer

- PMLiVE

NICE set to turn down Lilly’s lung cancer drug Alimta

Draft guidance doesn't recommend medicine's use as type of maintenance therapy

- PMLiVE

NICE recommends test to support choice of breast cancer treatment

Genomic Health’s Oncotype DX could avoid over-treatment using chemotherapy

Novartis building

Novartis’ Jakavi turned down by NICE for blood cancer

UK cost-effectiveness watchdog concerned about 'uncertainties' in data in draft guidance

- PMLiVE

SMC approves Eliquis, restricts use of Rienso

Pfizer-BMS' anticoagulant backed but Takeda's drug given second-line recommendation

ABPI and Luther Pendragon parted ways over tobacco lobbying

The Lancet calls on other healthcare organisations to sever ties with the agency

Sanofi’s Steve Oldfield to co-chair UK medicines access group

Takes over from UCB’s Matthew Speers in joint government/industry group

- PMLiVE

Creating the perfect partnership

Partnerships and collaboration between pharma and the NHS are crucial to the future success of both, so why then are there few shining examples?

- PMLiVE

Access Partnership expands its senior team

Kevin Mayo joins as VP in the US and Pascal King as global director in London

ABPI London offices

Three new members at ABPI

ALK- Abello, Shionogi and Randox join UK trade body

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links